C1-INH concentrate for treatment of acute hereditary angioedema: A pediatric cohort from the I.M.P.A.C.T. studies

Pediatric Allergy and Immunology

Volumn 24, Issue 1, 2013, Pages 54-60

  Schneider, Lynda ^a   Hurewitz, David ^b   Wasserman, Richard ^c   Obtulowicz, Krystyna ^d   Machnig, Thomas ^e   Moldovan, Dumitru ^f   Reshef, Avner ^g   Craig, Timothy J ^h  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Allergy Clinic of Tulsa Inc   (United States)

^c Allergy/Immunology Research Center of North Texas   (United States)

^d UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^e CSL BEHRING GMBH   (Germany)

^f Spitalul Cinic Judetean de Urgenta Mures   (Romania)

^g SHEBA MEDICAL CENTER   (Israel)

^h PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute attacks of hereditary angioedema; Berinert; C1 INH; Hereditary angioedema; PdC1 INH; Pediatric and adolescent patients; Plasma derived C1 esterase inhibitor

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ADOLESCENT; ANGIONEUROTIC EDEMA; ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNSPECIFIED SIDE EFFECT;

ADOLESCENT; AGED; ANGIOEDEMAS, HEREDITARY; CHILD; COHORT STUDIES; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872652108     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12024     Document Type: Article

References (21)

1. Fay A, Abinun M. Current management of hereditary angio-oedema (C-1 esterase inhibitor deficiency). J Clin Pathol 2002: 55: 266-70.
2. Nielsen EW, Johansen HT, Holt J, Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res 1994: 35: 184-7.
3. Farkas H. Pediatric hereditary angioedema due to C1-inhibitor deficiency. Allergy Asthma Clin Immunol 2010: 6: 18.
4. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006: 119: 267-74.
5. Farkas H, Harmat G, Füst G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 2002: 13: 153-61.
6. Farkas H, Varga L, Széplaki G, Visy B, Harmat G, Bowen T. Management of hereditary angioedema in pediatric patients. Pediatrics 2007: 120: e713-22.
7. Ebo DG, Verweij MM, De Knop KJ, et al. Hereditary angioedema in childhood: an approach to management. Paediatr Drugs 2010: 12: 257-68.
8. Bowen T, Cicardi M, Farkas H, et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010: 6: 24.
9. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005: 139: 379-94.
10. Wahn VW, Aberer W, Eberl W, et al. Hereditary angioedema (HAE) in children and adolescents-a consensus on therapeutic strategies. Eur J Pediatr 2012: 171: 1339-48.
11. Craig TJ, Wasserman RL, Levy RJ, et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J Clin Immunol 2010: 30: 823-9.
12. Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009: 124: 801-8.
13. Craig TJ, Bewtra AK, Bahna SL, et al. C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks - final results of the I.M.P.A.C.T.2 Study. Allergy 2011: 66: 1604-11.
14. Bernstein JA, Ritchie B, Levy RJ, et al. Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. Ann Allergy Asthma Immunol 2010: 105: 149-54.
15. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Von Hentig N, Klingebiel T, Kreuz W. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Transfusion 2010: 50: 354-60.
16. Donaldson VH, Rosen FS. Hereditary angioneurotic edema: a clinical survey. Pediatrics 1966: 37: 1017-27.
17. Shah UK, Jacobs IN. Pediatric angioedema: ten years' experience. Arch Otolaryngol Head Neck Surg 1999: 125: 791-5.
18. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Klingebiel T, Kreuz W, Goethe JW. Clinical surveillance program of pediatric hereditary angioedema (HAE) patients undergoing home treatment. J Allergy Clin Immunol 2009: 123 (Suppl): S116.
19. Cinryze® (C1 Esterase Inhibitor [Human]) US Prescribing Information. ViroPharma Biologics, Inc., Exton, PA. July 2012.
20. Bork K, Korger G, Kreuz W. Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate [poster]. Presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology, February 2-6, 2012.
21. Berinert® (C1 Esterase Inhibitor [Human]) US Prescribing Information. CSL Behring GmbH, Marburg, Germany. December 2011.